Haitong Pharmaceutical (600267.SH): Fumaric acid betadicaline raw material medicine receives notice of approval for market application.

Zhixin Finance and Economics App, Haizheng Pharmaceutical (600267.SH) announced that the company has recently received the "Chemical Raw Materials Market Application Approval Notice" for Fumaric Acid Bedaquiline Raw Materials issued by the National Medical Products Administration (referred to as the "National Medical Administration Bureau").